Effectiveness of Anidulafungin in Eradicating Candida Species in Invasive Candidiasis
Open Access
- 1 November 2005
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (11) , 4795-4797
- https://doi.org/10.1128/aac.49.11.4795-4797.2005
Abstract
In a phase 2 open-label, dose-ranging study in patients with candidemia, anidulafungin was effective in eradicating Candida albicans and other species of Candida . The anidulafungin MIC distribution showed that Candida albicans and C. glabrata were the most susceptible species and C. parapsilosis was the least susceptible species.Keywords
This publication has 17 references indexed in Scilit:
- Initial results from a longitudinal international surveillance programme for anidulafungin (2003)Journal of Antimicrobial Chemotherapy, 2004
- Further Standardization of Broth Microdilution Methodology for In Vitro Susceptibility Testing of Caspofungin against Candida Species by Use of an International Collection of More than 3,000 Clinical IsolatesJournal of Clinical Microbiology, 2004
- Phase 2, Randomized, Dose-Ranging Study Evaluating the Safety and Efficacy of Anidulafungin in Invasive Candidiasis and CandidemiaAntimicrobial Agents and Chemotherapy, 2004
- Has Antifungal Susceptibility Testing Come of Age?Clinical Infectious Diseases, 2002
- Epidemiology of Candidemia: 3-Year Results from the Emerging Infections and the Epidemiology of Iowa Organisms StudyJournal of Clinical Microbiology, 2002
- In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species† †This study was presented, in part, at the 37th ICAAC in Toronto, Canada, 28th September – 1st October 1997.Clinical Microbiology & Infection, 2001
- Structure–activity relationships of ketolides vs. macrolidesClinical Microbiology & Infection, 2001
- In vitro Susceptibility of Candida dubliniensis to Current and New Antifungal AgentsChemotherapy, 2000
- Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin BJournal of Antimicrobial Chemotherapy, 2000
- Activity of MK-0991 (l-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.Diagnostic Microbiology and Infectious Disease, 1998